New, improved treatments for Chagas disease: from the R&D pipeline to the patients - Wikidata - wikimedia - TriplyDB

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

http://www.wikidata.org/entity/Q21092295

about

Kinases as druggable targets in trypanosomatid protozoan parasites Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?Bigger data, collaborative tools and the future of predictive drug discovery Evaluation of spatially targeted strategies to control non-domiciliated Triatoma dimidiata vector of Chagas disease The unfinished public health agenda of chagas disease in the era of globalization.Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges The centennial of the discovery of Chagas disease: facing the current challenges Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.Chagas disease and the london declaration on neglected tropical diseases.Barriers to treatment access for Chagas disease in Mexico Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.Secondary kill effect of deltamethrin on Triatoma infestans New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.Access to care for Chagas disease in the United States: a health systems analysis Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation Advances in Chagas disease drug development: 2009-2010 Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.Reversible cysteine protease inhibitors show promise for a Chagas disease cure.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.Congenital transmission of Chagas disease: a clinical approach.Therapy of vector-borne protozoan infections in nonendemic settings.Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.The emerging role of amiodarone and dronedarone in Chagas disease.Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.Spatiotemporal analysis of reported cases of acute Chagas disease in the State of Pernambuco, Brazil, from 2002 to 2013.Mutagenic and Cytotoxicity LQB 123 Profile: Safety and Tripanocidal Effect of a Phenyl-t-Butylnitrone Derivative.Aromatic amine N-oxide organometallic compounds: searching for prospective agents against infectious diseases.Chagas Disease Infection among Migrants at the Mexico/Guatemala Border.The BENEFIT Trial: Where Do We Go from Here?Computational models for neglected diseases: gaps and opportunities.A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach.

P2860

Q26786761-4B9DE9E1-FA7B-4CCD-BAC9-02E7C9339416 Q28540817-7DB5C55B-0F68-4851-82EC-0A5EE3ED946F Q28545842-0EC3CD30-716C-4687-ACC4-FE17D3BCFF94 Q28548478-882866FD-A677-48CB-BEAB-39D348421695 Q28555229-09DDC174-3A0A-4E31-84C4-D001CEDDCF20 Q28654673-D6BEC5A1-D074-4051-BA64-7807CCB6D0DE Q28656268-F78CC4A3-09BE-45D2-ABFC-CA63F9B39879 Q33479112-230494F1-AC91-4338-88AE-CE16AE4DA70F Q33584473-31CD6097-2CC1-4153-B004-93BE4DC1CAFC Q33627688-62579903-E47C-4AC9-A29C-36659C2F9648 Q33955428-4E865AAE-7763-434C-A28A-39A761860328 Q34315066-07911AE1-5490-4328-83E5-2DAAAF1AD148 Q35023674-EA07FC13-A587-4B32-AD84-98378BFC8023 Q35130398-98485916-E456-4E7F-A22C-EA0670F150D7 Q35738489-5D659F33-6146-499F-AC43-4B8FC080548A Q35822254-4F4AED8F-A984-4895-BE3B-13BC5346119D Q35836581-939B1329-E9F6-4F57-ACA2-90996EE141DE Q36170517-F5306A1B-F065-437C-9C57-3DA386C61CCA Q36278397-D4964055-FE2B-4D36-96AD-ACF660299816 Q36702159-46728D15-B7F4-4CE8-B7ED-C9E6051E1646 Q36933398-0E56EC77-02B1-4A4E-B256-6B99C72D30D8 Q37023164-5FC6F0CB-DE6A-489B-8B12-180AA743F5DA Q37124216-9DB678C9-83BE-4FEE-AED5-00B2180F04D5 Q37544765-6C72A6C3-2199-4728-90FC-CE45F2223FBA Q37717875-33EEE340-FD78-45B1-A113-1064E10B1437 Q37744965-7C83A442-248F-4A1D-A2D8-B838421292DE Q37778830-BD405303-6745-49B6-B9FA-2C581F0321A0 Q37879203-2625B3EB-6A2F-4257-AC67-D49B9BEA4143 Q37998091-5B884479-4F40-47B4-8539-72599F6F8D21 Q38032507-54EF40ED-0F8B-447C-84C6-08C96E010AA1 Q38256874-645FBF5A-4C0F-4206-AE97-BAA0EE4D752D Q40281916-9200E8E9-74CC-42F8-AFA0-C27EEDA5865E Q40288847-BA7C34DF-B5B5-40D0-9365-BFD00AB36F65 Q41093486-EEF321C4-A6E4-446A-81AF-6833CC4F0409 Q41920978-E23E497E-A7C4-4CD9-99AD-2F84F12FE19B Q42592597-39C802DD-939F-4787-9A90-892DE7EB8ED9 Q44083547-FB5B9466-F628-4A00-BE88-9DB4419E2070 Q44504229-A65C5FCD-56A5-4CD9-8BDB-9C3D535A5369 Q46735046-BE4BD490-8975-44DB-8302-C713537E9EC8 Q47872103-DB65BCAF-7BE0-495F-8A2F-E8A570D4932F

P2860

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

http://www.wikidata.org/entity/Q21092295

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@ast

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en-gb

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@nl

type

label

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@ast

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en-gb

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@nl

altLabel

New, Improved Treatments for Chagas Disease: From the R&D; Pipeline to the Patients

@en

prefLabel

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@ast

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en-gb

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@nl

P1433

Q21092295-24A50994-700A-435A-9B21-C6ABA24835EE

P1476

Q21092295-BC28379C-92F1-4CA9-965A-38E85CF5CA8B

P2093

Q21092295-35392D58-E7CC-41EB-9065-9EEF197C5B12

Q21092295-69A4B406-3D92-4B93-9EDD-00CBA07763E0

Q21092295-A5AA0407-13BD-468D-B4D8-8796AF14A21B

Q21092295-ABFB55A6-5A7D-4EF1-AE81-58258C387B78

Q21092295-B54D2BE2-8671-4CD3-AEB4-1D35122B5B3F

Q21092295-D5F67D78-EF8C-484A-A9DB-36BE03C7973A

Q21092295-F356A1A9-5460-4EA9-9C4F-A913D1356E0A

P275

Q21092295-249AA9CE-D771-459F-ADA2-0588186143A9

P2860

Q21092295-122F928A-CD33-48C4-9539-37E28CBF63FD

Q21092295-1461A85F-1077-4286-99C9-9712234829A4

Q21092295-1C8BDA9B-A2AB-49E9-BEF0-A713581CDEF8

Q21092295-1D88D7A0-F4F5-4F01-A92E-6F9CD5A4DC3D

Q21092295-1EED7156-4539-496D-8EFF-9E20EAA18CF2

Q21092295-244999F7-B1CE-44F8-A3C3-9AF5A624E5C9

Q21092295-29D8DF52-DFF3-49B0-A77B-488CA1C19747

Q21092295-2AB64014-F906-4ABF-B98B-B0098F379FA8

Q21092295-2CB4C3CB-A6F8-4EAC-BA17-C958D6DB39BA

Q21092295-355A432D-DC51-4DCF-B3DB-5D55F6985F32

P304

Q21092295-74AB8476-77E8-463C-B815-3961BB61DB3D

P31

Q21092295-F32F1982-0B10-4E03-BBAC-D2B009A0C4F3

Q21092295-F8C75CFE-C1EA-4056-9D35-3F12D8B5C547

P3181

Q21092295-594A44BE-02CF-4735-B106-E4CC01BF5A78

P356

Q21092295-232B09AF-1C9D-46C9-97C1-2072B2B0EC36

P407

Q21092295-ABAC7786-AED8-4C16-8600-4CDCCA0A8595

P433

Q21092295-32E66355-B17B-42ED-A7FD-09253BF9D577

P478

Q21092295-59B46135-9FCC-4A66-82CC-ACEB58229D7E

P50

Q21092295-7510819E-C36A-4479-A21B-07864F2B5C1A

P5008

Q21092295-E6CCAD8D-600B-4CA8-BAAF-D0158F77B354

P577

Q21092295-A60A163E-0545-46F9-95B0-647771F1AD3A

P5875

Q21092295-6C0E15A1-2205-41F1-B65B-275920BDDF7A

P698

Q21092295-3DDB5AC6-FC65-464B-97FF-8C0F80D6AB4D

P921

Q21092295-6099DD41-4862-4007-9B84-EFFAC46AD7C9

Q21092295-73EC331A-044A-459E-8479-17134E9AE074

Q21092295-C46034C7-076E-4973-B723-76E90D8BAC68

P932

Q21092295-4C8F2BDB-6BA7-4B09-86B7-04A4F3076E41

P3181

P356

JOURNAL.PNTD.0000484

P1433

PLOS Neglected Tropical Diseases

P1476

New, improved treatments for Chagas disease: from the R&D pipeline to the patients

@en

P2093

Ann-Marie Sevcsik

http://www.w3.org/2001/XMLSchema#string

Bernard Pecoul

http://www.w3.org/2001/XMLSchema#string

Fabiana Alves

http://www.w3.org/2001/XMLSchema#string

Graciela Diap

http://www.w3.org/2001/XMLSchema#string

Isabela Ribeiro

http://www.w3.org/2001/XMLSchema#string

Robert Don

http://www.w3.org/2001/XMLSchema#string

Shing Chang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Neglected disease research and development: how much are we really spending?

Measuring the burden of neglected tropical diseases: the global burden of disease framework

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

Safety of the blood supply in Latin America

A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection

New drugs for neglected diseases: from pipeline to patients

A breakthrough in R&D; for neglected diseases: new ways to get the drugs we need

Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function

The challenges of Chagas Disease-- grim outlook or glimmer of hope.

P304

e484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1777725

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PNTD.0000484

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michael O. Harhay

P5008

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26651936

http://www.w3.org/2001/XMLSchema#string

P698

19582163

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

2702098

http://www.w3.org/2001/XMLSchema#string